400 followers
RT @FrontPharmacol: New Research: Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïv…
RT @FrontPharmacol: New Research: Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïv…
New Research: Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma—A network meta-analysis. Focus on cabozantinib combined with nivolumab https://t.co/Ey4hW3E4